Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Eisana Corporation currently has 1 pending office action in the Medical Devices & Mechanical Engineering technology area. The prosecution landscape for this company is focused, involving 1 distinct examiner and 1 distinct art unit. This indicates that the company's current intellectual property efforts are concentrated in a single technical and administrative niche.
The busiest examiner for this portfolio is PAPE, ALYSSA MORGAN, who is currently handling 1 busiest examiner pending office action. Because the portfolio only contains 1 distinct examiner, PAPE, ALYSSA MORGAN is responsible for the entirety of the company's pending office actions. This concentration allows for a singular focus in prosecution strategy as there are no other examiners to account for.
The 1 distinct art unit involved shows that the technical review is confined to one specific group. The 1 pending office action represents the total active workload for the company's portfolio. This streamlined profile suggests that the company is currently managing a specific set of patent claims under the oversight of 1 distinct examiner.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PAPE, ALYSSA MORGAN | 1 | 28.0% | +43.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17759593 | SYSTEM AND METHOD FOR MITIGATING SIDE EFFECTS OF CHEMOTHERAPY | PAPE, ALYSSA MORGAN | 48d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17759593 | SYSTEM AND METHOD FOR MITIGATING SIDE EFFECTS OF CHEMOTHERAPY | PAPE, ALYSSA MORGAN | 48d |
| Art Unit | Apps |
|---|---|
| 3794 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17759593 | SYSTEM AND METHOD FOR MITIGATING SIDE EFFECTS OF CHEMOTHERAPY | PAPE, ALYSSA MORGAN | 3794 | §103 | Non-Final OA | 48d | Pending | Jul 27, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial